Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-3-1
pubmed:abstractText
This study aims to assess the efficacy and safety of sunitinib in Japanese patients with metastatic renal cell carcinoma (RCC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1465-3621
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
194-202
pubmed:meshHeading
pubmed-meshheading:19897852-Adult, pubmed-meshheading:19897852-Aged, pubmed-meshheading:19897852-Antineoplastic Agents, pubmed-meshheading:19897852-Bone Neoplasms, pubmed-meshheading:19897852-Carcinoma, Renal Cell, pubmed-meshheading:19897852-Female, pubmed-meshheading:19897852-Humans, pubmed-meshheading:19897852-Indoles, pubmed-meshheading:19897852-Japan, pubmed-meshheading:19897852-Kidney Neoplasms, pubmed-meshheading:19897852-Lung Neoplasms, pubmed-meshheading:19897852-Lymphatic Metastasis, pubmed-meshheading:19897852-Male, pubmed-meshheading:19897852-Middle Aged, pubmed-meshheading:19897852-Neoplasm Staging, pubmed-meshheading:19897852-Prognosis, pubmed-meshheading:19897852-Pyrroles, pubmed-meshheading:19897852-Safety, pubmed-meshheading:19897852-Survival Rate, pubmed-meshheading:19897852-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
A phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma: insights into the treatment, efficacy and safety.
pubmed:affiliation
Department of Urology, University of Tsukuba, Graduate School of Comprehensive Human Sciences, Tsukuba 305-8576, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II